RETN and cardiovascular disorder: Despite initial controversies regarding its association with insulin resistance in clinical studies, resistin consistently correlates with obesity, systemic inflammation, and cardiometabolic dysregulation, functioning as a molecular bridge between adipose tissue dysfunction and cardiovascular disease (4).